Ovral is a brand-name combined oral contraceptive (COC) that contains two active ingredients: ethinyl estradiol (an estrogen) and norgestrel (a progestogen). It is marketed in pill form and is available in two strength options: 0.15 mg/0.03 mg and 0.5 mg/0.05 mg of ethinyl estradiol/norgestrel, respectively. In Hong Kong, Ovral is a prescription-only medication regulated by the Department of Health.
Ovral prevents pregnancy by delivering a steady dose of estrogen and progestogen:
These actions begin within the first few days of consistent use. The hormonal levels remain fairly constant because the pill is taken daily, leading to predictable onset, peak, and duration of effect.
Ovral is not approved for the treatment of conditions such as acne, endometriosis, or hormonal therapy beyond contraception, unless a clinician determines off-label use after evaluating the evidence.
Some clinical studies have examined combined oral contraceptives containing ethinyl estradiol and norgestrel for:
These effects are usually transient and improve with continued use.
Note: Patients should disclose all medications, supplements, and herbal products to their healthcare provider before starting Ovral.
This article provides educational information about Ovral and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Ovral pills are legal to carry for personal medical use in Hong Kong and most destinations. Keep the medication in its original packaging with the prescription label visible, and carry a copy of the prescription if possible to ease security checks.
Take another tablet as soon as you can, then continue with the regular schedule. If vomiting recurs, use a non-hormonal backup method (e.g., condom) for the next seven days and contact your clinician.
Ovral tablets are typically round, white to off-white, with the imprint “OVRAL” followed by the dosage strength (e.g., “0.15/0.03”). The exact appearance may vary by manufacturer.
Hormonal contraceptives are not screened for in standard workplace or athletic drug tests. However, if you are subject to specialized testing (e.g., for estrogen levels), disclose your medication to the testing authority.
Yes, most clinicians advise starting Ovral on the first day of the next menstrual cycle or on the scheduled start day of your previous pill, without an additional gap. Follow your prescriber’s specific instructions.
Some women report mild fluid retention or increased appetite, but clinical studies have not demonstrated a consistent, significant weight gain directly attributable to Ovral.
No specific diet is required. However, maintaining a balanced diet and limiting excessive caffeine or alcohol can help manage side effects like headache or breast tenderness.
Ovral is intended for long-term use as needed for contraception. Periodic medical review (e.g., every 1-2 years) ensures continued suitability and monitors for potential risks.
Keep the bottle in a sealed plastic bag away from direct heat, such as inside a cooler compartment of your luggage. Avoid exposing the medication to temperatures above 30 °C for prolonged periods.
